Morgan Stanley lowered the firm’s price target on Inspire Medical (INSP) to $220 from $230 and keeps an Overweight rating on the shares. Though ...

RBC Capital Markets upheld a positive outlook on Inspire Medical Systems (NYSE:INSP) shares, reiterating an Outperform rating with a steady price target of $260.00. The stock currently trades at $180.

Microbot Medical Inc. (Nasdaq: MBOT) today announced the closing of its previously announced registered direct offering ...

The improved performance came in the period premiums from medical insurance rose 22.8 percent to Sh46.3 billion.

In Ohio, the average cost of marijuana per ounce is $192.40. That’s more than double the cost in Michigan where the average ...

If enacted in 2022, the Fair Pricing Act could have saved patients up to $213.4 million in out-of-pocket costs, research says.

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Morgan Stanley (NYSE:MS) adjusted its outlook on Inspire Medical Systems (NYSE:INSP), reducing the price target from $230.00 to $220.00, yet continuing to endorse the stock with an Overweight rating.

The average price of bud has fallen gradually, numbers show. Recreational sales grew 2.5% last year, with dispensaries ...

After a rough 2024, Teladoc Health (TDOC) has seen its shares surge up roughly 45% year-to-date, catalyzed by a recent ...

Since abrdn's acquisition in 2023, HQL has delivered a total return of 25.5%, though its price appreciation has been modest.